• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

CorMedix (CRMD)

Common Shares
Sell: $11.41|Buy: $11.64|Change: 0.25 (-2.13%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Address

400 Connell Drive
Suite 5000
Berkeley Heights
NJ
USA
07922

Telephone

+1 908 5179500

Website

https://www.cormedix.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Cormedix Inc Third Quarter Earnings Conference Call for 20262026-11-12T08:30:00
Cormedix Inc Third Quarter Earnings Results for 20262026-11-12T00:00:00
Cormedix Inc Second Quarter Earnings Conference Call for 20262026-08-07T08:30:00
Cormedix Inc Second Quarter Earnings Results for 20262026-08-07T00:00:00
Cormedix Inc Annual General Meeting for 20262026-06-24T09:00:00
Cormedix Inc First Quarter Earnings Conference Call for 20262026-05-06T08:30:00
Cormedix Inc First Quarter Earnings Results for 20262026-05-06T00:00:00
Cormedix Inc Fourth Quarter Earnings Conference Call for 20252026-03-25T08:30:00
Cormedix Inc Fourth Quarter Earnings Results for 20252026-03-25T00:00:00
Cormedix Inc Annual Report for 20252026-03-25T00:00:00

Previous key dates

NameKey Date
Cormedix Inc Third Quarter Earnings Conference Call for 20252025-11-12T08:30:00
Cormedix Inc Third Quarter Earnings Result for 20252025-11-12T00:00:00
Morgan Stanley 23rd Annual Global Healthcare Conference2025-09-10T10:45:00
Cantor Global Healthcare Conference2025-09-05T08:35:00
Cormedix Inc Second Quarter Earnings Conference Call for 20252025-08-07T08:30:00
Cormedix Inc Second Quarter Earnings Result for 20252025-08-07T00:00:00
Cormedix Inc Annual General Meeting for 20252025-06-24T09:00:00
Jefferies Global Healthcare Conference2025-06-05T15:45:00
RBC Capital Markets Global Healthcare Conference2025-05-21T15:05:00
Cormedix Inc First Quarter Earnings Conference Call for 20252025-05-06T08:30:00
Cormedix Inc First Quarter Earnings Results for 20252025-05-06T00:00:00
24th Annual Needham Virtual Healthcare Conference2025-04-08T14:15:00
Cormedix Inc Fourth Quarter Earnings Conference Call for 20242025-03-25T08:30:00
Cormedix Inc Fourth Quarter Earnings Results for 20242025-03-25T00:00:00
Cormedix Inc Annual Report for 20242025-03-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.